November 22nd 2024
A new study shows that COVID-19 infection significantly increases the risk of exacerbation in patients with myasthenia gravis (MG).
Disinfectant Linked With Reduced Hospital-Onset Clostridioides difficile Infection
July 13th 2022Hospital ward cleaning with potassium peroxymonosulphate-based environmental disinfectant and a decrease in days of therapy with carbapenems were associated with a reduction in the rate of hospital-onset Clostridioides difficile infection.
Read More
Improving the Mental Health of Children Through School-Based Prevention, Intervention Services
July 12th 2022On this episode of Managed Care Cast, we find out about efforts by a managed Medicaid health care plan in Southern California to bring prevention and intervention mental health services to schools in response to a worsening crisis among America's children and adolescents.
Listen
Contributor: Providers and Employers Need to Collaborate More to Avoid a Greater Crisis
July 12th 2022It can be hard to think about the bigger picture while in the middle of a crisis, but providers and employers should use this opportunity to work together on new and alternative models of care delivery and financing that directly affect cost, outcomes, and experience.
Read More
Stakeholders List 6 Actionable Steps to Ameliorate Global Disparities in Parkinson Disease
July 11th 2022Advocacy and awareness; prevention and risk reduction; diagnosis, treatment, and care; caregiver support; and research were listed as actionable steps that are urgently needed to address global disparities in Parkinson disease.
Read More
Provider and Patient Insights Into the Cancer Care Journey
A survey was conducted to determine opportunities to aid primary care providers and patients in the difficult journey of an oncology patient.
Read More
Contributor: Technology, Supplemental Services in MA Can Help Improve Participant Health
July 10th 2022Social determinants of health present many health-related challenges for Medicare Advantage (MA) plan members, something these plans are looking to overcome by diversifying their service offerings.
Read More
Certain Factors May Reduce ESS-Induced Smell Improvement in CRSwNP
July 9th 2022Endoscopic sinus surgery was associated with improvement in self-reported olfactory function among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), in which a longer CRSwNP disease course and higher blood eosinophilia were cited as risk factors linked with poor sense of smell recovery.
Read More
Potential Link Found Between Heart Failure Prognosis, Changes in RVFAC
July 8th 2022Few data exist on how right ventricular fractional area change (RVFAC) may contribute to outcomes among patients hospitalized for heart failure, so that potential relationship was investigated in this new study from Japan.
Read More
Targeting β Cells May Hold Promise for Preventing and Treating T1D
July 7th 2022Although the autoimmune response that reduces β cell numbers has often been the focus of research in type 1 diabetes (T1D), findings from a new study suggest proinflammatory signaling in islet β cells may play a significant role in disease progression.
Read More
Drug Survival of Psoriasis Biologics Associated With Efficacy, Safety Profile
July 6th 2022Drug survival rates of biologics in patients with psoriasis were shown to be associated with their effectiveness and safety profiles, in which incidence of psoriatic arthritis, nail involvement, and other factors were indicated as effect modifiers.
Read More
Evaluating Value-Based Contracting in Behavioral Health: A Q&A With Vanessa Bobb, MD, PhD, FAPA
July 5th 2022At AHIP 2022, Vanessa Bobb, MD, PhD, FAPA, vice president of Behavioral Health & Medical Integration at CDPHP, moderated a session on real-world study findings showcasing cost and quality benefits of value-based contracting in behavioral health. Bobb discusses findings of the study and how value-based programs can be better leveraged in mental health and substance abuse care.
Read More
Dupilumab Demonstrates Safety, Efficacy Across Several Type 2 Inflammatory Diseases
July 2nd 2022Research presented at the European Academy of Allergy and Clinical Immunology Annual Congress show the safety and efficacy of dupilumab across several progressive diseases with underlying type 2 inflammation, including eosinophilic esophagitis (EoE), severe asthma, and severe chronic rhinosinusitis with nasal polyps.
Read More
Dr Elaine Siegfried on Preventive Strategies to Reduce Comorbidity Risk in Atopic Dermatitis
July 2nd 2022Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, addresses the comorbidity profile associated with atopic dermatitis and the utility of disease-modifying drugs to reduce risk of comorbid conditions.
Watch